University of Tasmania, School of Pharmacy Bio-analytical contract research and drug discovery
Overview
.jpg)
The School of Pharmacy at the University of Tasmania has considerable expertise in the biotech area and undertakes contract research and collaborative projects with industry over a diverse range of projects. Contract research focuses on difficult and specialised bio-analytical applications and method development for novel drug delivery and biotechnology research, utilising LC-MS (ESI, APCI), multidimensional nanoflow LC-MS for proteomics applications, HPLC-DAD, HPLC-FD, HPLC-ELSD (carbohydrate analyses), ICP-MS, GC-MS. Areas of expertise include low molecular weight heparin analyses, chiral assays, proteomics, and peptide analyses of both novel dosage forms and biological matrices. The University offers extensive analytical experience and capabilities with access to start of the art instrumentation encompassing a wide range of applications including analytical and semi-preparative techniques. Current project areas include anti-infectives, antioxidants, anticancer, antithrombotics, muscle wasting diseases, and dermatology. In particular, characterisations of flavonoids and essential oils with a focus on skincare including onychomycosis, psoriasis and topical veterinary conditions are being undertaken. The University and it’s partners are actively seeking investors and industry partners for commercialisation of exciting products and technologies.
Number of employees: <10
Main business focus/
Listing by sector:
- Service Provider
- Drug Discovery & Development
- Biodiscovery
- Dermatology
- Nutraceuticals
Competitive Advantages
Small experienced research group, extensive analytical experience and capabilities with access to state of the art instrumentation encompassing a wide range of applications. Efficient and cost effective quality service. Experience in undertaking novel assay method development for a variety of applications.
Technology/IP
- Chiral separations including beta2-agonists in a variety of biological matrices.
- High resolution LC-MS/MS (ESI or APCI).
- Highly sensitive multidimensional nanoflow LC-MS for functional proteomics.
- HPLC-DAD, HPLC-FD, HPLC-ELSD (carbohydrate analyses), ICP-MS, GC-MS/MS including SPME.
- Novel assays for extensive chemical and anti-factor Xa characterisation of low molecular weight heparins.
- Access to unique biological resources with well characterised extracts having demonstrated biological activities.
Corporate Alliances/Partnerships
Botanical Resources Australia Pty Ltd
Stirling Products Pty Ltd
Partnering Opportunities
- High resolution separations for low molecular weight heparin products, scale-up, chemical and anti-factor Xa characterisation (licensing, technology transfer, contract research).
- Quantitative proteomics methods for identification of disease markers in muscle wasting diseases, anti-doping control, gastrointestinal dysplastic/metaplastic conditions including Barrett’s Oesophagus (licensing, technology transfer and contract research).
- Psoriasis treatment based on a natural product essential oil (licensing, sales).
- Onychomycosis treatment based on a natural product essential oil (licensing, sales).
- Highly potent novel natural product juice suitable for nutraceuticals (licensing, sales).
- Analytical contract research.
Contact Details
| Contact person | Dr Glenn Jacobson |
|---|---|
| Job Title | Senior Lecturer |
| Address | Private Bag 26 |
| City/Suburb | Hobart |
| State | Tasmania |
| glenn.jacobson@utas.edu.au | |
| Phone | +61 3 6226 2190 |
| Fax | +61 3 6226 2870 |
| Website | http://www.pharmacy.utas.edu.au/research.html |
